Merck & Co. Inc. stock underperforms Friday when compared to competitors
Shares of Merck & Co. Inc. MRK slipped 0.37% to $109.77 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and ...
bovnews6h
Merck & Co Inc (MRK) Stock’s -0.04% Decrease This Year: What’s the Story?
Societe Generale has recently reduced Merck & Co Inc (MRK) stock to Sell rating, as announced on March 11, 2024, according to Finviz. Earlier, on January 4, 2024, TD Cowen had raised the stock from a ...
Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August
An analysis of Q3 layoffs in pharmaceutical and biotech companies shows a decline in numbers as the summer progressed. Read ...
Could Summit Therapeutics Become the Next Merck?
Summit Therapeutics (NASDAQ: SMMT). This California-based biotech is developing a cancer medicine that has produced excellent clinical trial results in one area where Keytruda is the leader. Summit ...
Should Weakness in Merck & Co., Inc.'s (NYSE:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% ...